| SC 13G/A | 2023-02-13 | Lind Global Fund II LP | Kintara Therapeutics, Inc. | 75,472 | - | EDGAR |
| SC 13G | 2022-04-20 | Lind Global Fund II LP | Kintara Therapeutics, Inc. | 3,773,586 | - | EDGAR |
| SC 13G/A | 2022-02-07 | Pilkiewicz Carolyn | Kintara Therapeutics, Inc. | 1,170,290 | 2.4% | EDGAR |
| SC 13G/A | 2021-02-08 | Pilkiewicz Carolyn | Kintara Therapeutics, Inc. | 1,732,789 | 7.0% | EDGAR |
| SC 13G/A | 2021-01-29 | INTRACOASTAL CAPITAL, LLC | Kintara Therapeutics, Inc. | 900,125 | 3.5% | EDGAR |
| SC 13G | 2020-11-16 | Pilkiewicz Carolyn | Kintara Therapeutics, Inc. | 2 | 9.2% | EDGAR |
| SC 13G | 2020-08-28 | STERN ADAM K | Kintara Therapeutics, Inc. | 1,653,970 | 7.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Anson Funds Management LP | DelMar Pharmaceuticals, Inc. | 290,125 | 1.5% | EDGAR |
| SC 13G/A | 2020-02-11 | INTRACOASTAL CAPITAL, LLC | DelMar Pharmaceuticals, Inc. | 700,000 | 5.8% | EDGAR |
| SC 13G/A | 2020-02-10 | CVI Investments, Inc. | DelMar Pharmaceuticals, Inc. | 599,131 | 4.9% | EDGAR |
| SC 13G/A | 2020-01-23 | Empery Asset Management, LP | DelMar Pharmaceuticals, Inc. | 1,440,125 | 5.0% | EDGAR |
| SC 13G/A | 2020-01-21 | SABBY MANAGEMENT, LLC | DelMar Pharmaceuticals, Inc. | 34,615 | 0.3% | EDGAR |
| SC 13G | 2019-08-23 | CVI Investments, Inc. | DelMar Pharmaceuticals, Inc. | 675,000 | 8.5% | EDGAR |
| SC 13G | 2019-08-23 | INTRACOASTAL CAPITAL, LLC | DelMar Pharmaceuticals, Inc. | 908,021 | 10.0% | EDGAR |
| SC 13G | 2019-06-13 | Anson Funds Management LP | DelMar Pharmaceuticals, Inc. | 295,000 | 7.7% | EDGAR |
| SC 13G | 2019-06-12 | INTRACOASTAL CAPITAL, LLC | DelMar Pharmaceuticals, Inc. | 198,244 | 5.0% | EDGAR |
| SC 13G | 2019-06-05 | Empery Asset Management, LP | DelMar Pharmaceuticals, Inc. | 292,500 | 7.6% | EDGAR |
| SC 13G/A | 2019-02-08 | INTRACOASTAL CAPITAL, LLC | DelMar Pharmaceuticals, Inc. | 635,833 | 2.5% | EDGAR |
| SC 13G/A | 2019-01-25 | FRANKLIN RESOURCES INC | DelMar Pharmaceuticals, Inc. | 807,693 | 3.1% | EDGAR |
| SC 13G/A | 2019-01-07 | SABBY MANAGEMENT, LLC | DelMar Pharmaceuticals, Inc. | 689,499 | 2.7% | EDGAR |